Evidence map›Paper›PMID 35068350›Full record

ArticleBioengineered2022

BUB1B (BUB1 Mitotic Checkpoint Serine/Threonine Kinase B) promotes lung adenocarcinoma by interacting with Zinc Finger Protein ZNF143 and regulating glycolysis.

Xiaolei Zhou, Yanli Yuan, Hongping Kuang, Bingxiang Tang, Hui Zhang, Manlin Zhang

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. mTranslational oncology · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiaolei ZhouDepartment of Respiratory and Critical Medicine, Henan Chest Hospital, Zhengzhou, P.R. China.
Yanli YuanDepartment of Respiratory and Critical Medicine, Henan Chest Hospital, Zhengzhou, P.R. China.
Hongping KuangDepartment of Respiratory and Critical Medicine, Henan Chest Hospital, Zhengzhou, P.R. China.
Bingxiang TangDepartment of Respiratory and Critical Medicine, Henan Chest Hospital, Zhengzhou, P.R. China.
Hui ZhangDepartment of Respiratory and Critical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P.R. China.
Manlin ZhangDepartment of Respiratory and Critical Medicine, Henan Chest Hospital, Zhengzhou, P.R. China.
Henan Provincial Chest Hospital · CNFirst Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung adenocarcinoma (LUAD) is one of the most common causes of cancer death in men. BUB1B (BUB1 mitotic checkpoint serine/threonine kinase B) has been reported to contribute to the initiation and development of several cancers. Here, we aimed to explore the potential role of BUB1B in LUAD. We found BUB1B was upregulated in LUAD, suggesting its potential role as a biomarker for LUAD diagnosis. Significantly, LUAD patients with high BUB1B expression had a shorter survival time than those with low BUB1B expression. Knocking-out BUB1B resulted in suppression of cell proliferation, migration, and invasion

Indexed as

GlycolysisA549 CellsAdenocarcinoma of LungCell Cycle ProteinsHumansLung NeoplasmsNeoplasm ProteinsProtein Serine-Threonine KinasesTrans-ActivatorsBUB1B protein, humanCell Cycle ProteinsNeoplasm ProteinsProtein Serine-Threonine KinasesTrans-ActivatorsZNF143 protein, humanBUB1Bglycolysislung adenocarcinomatranscriptional activatorZNF143

Identifiers

PMID35068350
PMCPMC8974056
OpenAlexW4206188361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.